Actinic Keratosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Actinic Keratosis Treatment Market Analysis

The actinic keratosis treatment market is expected to register a CAGR of 5.3% during the forecast period.

The COVID-19 pandemic had a significant impact on the actinic keratosis treatment market. There was a decrease in the number of aesthetic procedures performed worldwide during the COVID-19 pandemic to reduce the risk of viral transmission. For instance, according to an article published by Elsevier Public Health Emergency Collection, in February 2021, during the crisis, dermatologists were involved in managing cutaneous manifestations related to COVID-19 and occupational disease caused by personal protective equipment. The reduction in the number of procedures was attributed to the fear and risk of infection from COVID-19. However, with the adoption of telemedicine and teleconsultations during the pandemic, the demand for dermatological treatment increased, which led to a rise in the demand for actinic keratosis treatment. However, as COVID-19 cases have declined and the pandemic accelerated the use of teledermatology, the studied market is expected to project stable growth over the studied period.

The increasing prevalence of actinic keratosis, growing demand for minimally invasive procedures, and increasing research and development for developing novel therapies are the key driving factors in the market. For instance, according to an article published by the Indian Journal of Dermatology, in April 2022, actinic keratosis is one of the most frequently seen signs in the outpatient setting and was diagnosed at more than 10% of dermatology visits. In the UK, 15%-23% of individuals have actinic keratosis lesions, and this reaches 37.5% among people older than 50 years of age. This is likely to increase the adoption of the available treatment and early diagnosis of the disease. Furthermore, according to an article published by MDPI, in June 2022, photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is an emerging treatment option in the care of actinic keratosis. This increase in the prevalence of actinic keratosis leading to a surge in minimally invasive procedures such as photodynamic therapy is expected to aid the overall market growth in the studied period.

The recent product launches by the key market players are also aiding the market growth. For instance, in November 2022, Biofrontera Inc. launched a randomized, double-blind, vehicle-controlled, multicenter Phase 3 clinical study to evaluate the safety and efficacy of Ameluz and BF-RhodoLED XL in the field-directed treatment of actinic keratosis (AK) on the extremities, neck, and trunk. Furthermore, in September 2021, Almirall, S.A. launched Klisyri (tirbanibulin) in Germany and the U.K. The product was launched upon approval from the U.K.'s Medicines & Healthcare Products Regulatory Agency (MHRA) and the European Commission for treating actinic keratosis of the scalp and face in adults.

Risk factors associated with available treatment options may restrain the market growth over the forecast period.

Actinic Keratosis Treatment Market Trends

This section covers the major market trends shaping the Actinic Keratosis Treatment Market according to our research experts:

Photodynamic Therapy Segment is Expected to Hold a Significant Market Share in the Actinic Keratosis Treatment Market

Actinic Keratosis Treatment Industry Segmentation

As per the scope of the report, actinic keratosis is a rough, scaly patch on skin that develops from years of exposure to solar radiation. It is commonly found on the face, lips, ears, back of hands, forearms, scalp, or neck. 

The Actinic Keratosis Treatment Market is Segmented By Therapy Type (Topical Medications (Fluorouracil, Imiquimod, Ingenol Mebutate, and Other Medications), and Procedures (Photodynamic Therapy, Laser, and Other Procedures)), End User (Hospitals and Oncology Centers, Dermatology Clinics, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the market size and forecasts in value (USD million) for the above segments.